The 2013 TnSAM Addiction Medicine Conference, to be held August 29th and 30th, 2013, in Chattanooga, Tennessee is NOW OPEN for registration. Click here to register.
The Tennessee Society of Addiction Medicine and the American Society of Addiction Medicine are proud to present:
2 Conferences approved for a total of 15 AMA PRA Category 1 Credits:
ER/LA Opioid REMS: Achieving Safe Use While Improving Patient Care
Approved for 3 AMA PRA Category 1 Credits, at no charge
The 2013 TnSAM Addiction Medicine Conference
Approved for 12 AMA PRA Category 1 Credits, see registration fees below
August 29th and 30th 2013
University of Tennessee Chattanooga
University Center Auditorium, Chattanooga, Tennessee
In association with the Council for Alcohol & Drug Abuse Services, Inc. and the
Tennessee Association of Alcohol, Drug & other Addiction Services
Cost and Registration
- $200 – Physicians
- $150 – Nurse Practitioners & Physician Assistants
- $125 – TNSAM members
- $100 – Counselors, Social Workers, Psychologists, and Others
- $50 – CADAS employees, medical students and residents
- Clergy Free (as space permits)
- Speakers Free
Register early. Space is limited.
Payment types: credit cards online; checks and cash at the door.
ER/LA Opioid REMS:
Achieving Safe Use While Improving Patient Care
FDA statistics indicate that more than 33 million Americans, teens and older, misused extended-release and long-acting (ER/LA) opioids during 2007, up from 29 million in 2002. Yet these drugs have long been a major tool in the management of chronic pain or to help those who suffer from a painful injury or surgery. Highly effective yet highly addictive, the challenge posed by ER/LA opioids—patient assessment, prescribing guidelines, managing treatment and addressing alternatives when opioids fail—are the critical issues addressed by this course:
Thursday, August 29, 2013, 8:30 a.m. to 12 noon
University of Tennessee Chattanooga
University Center Auditorium
About the Course
The ER/LA Opioid REMS: Achieving Safe Use While Improving Patient Care course, presented at no charge through an unrestricted educational grant from ASAM, was developed by nationally known experts in the ER/LA opioid field. Presented through a variety of formats including lecture, case study, interactive audience response activities, and open discussion, ASAM’s REMS course is CO*RE-branded material, but will also include a special focus on addiction medicine. Participants can earn up to 3 AMA PRA Category 1 CME credit(s)™ upon completion of the course assessment and evaluation.
- Assessing Patients for Treatment with ER/LA Opioid Analgesic Therapy & Case Study
- Initiating Therapy, Modifying Dosing, and Discontinuing Use of ER/LA Opioid Analgesics & Case Study
- Managing Therapy with ER/LA Opioid Analgesics & Case Study
- Counseling Patients & Caregivers about Safe Use of ER/LA Opioid Analgesics & Case Study
- General Drug Information for ER/LA Opioid Analgesics
- Specific Drug Information for ER/LA Opioid Analgesic Products
- Is My Patient Opioid Addicted? — Diagnosis and Management & Case Study
- Opioid Jeopardy – an Audience Interactive Learning Session
Who Should Attend
The intended audience includes: addiction medicine physicians, psychiatrists, neurologists, psychologists, therapists, marriage and family therapists, addiction counselors, social workers, and any health care professionals working with addiction, smoking cessation or pain management related issues.
Goals and Objectives
- Describe appropriate patient assessment for treatment with ER/LA opioid analgesics, evaluating risks and potential benefits of ER/LA therapy as well as possible misuse.
- Apply proper methods to initiate therapy, modify dose, and discontinue use of ER/LA opioid analgesics, applying best practices including accurate dosing and conversion techniques as well as appropriate discontinuation strategies.
- Demonstrate accurate knowledge about how to manage ongoing therapy with ER/LA opioid analgesics, properly use evidence based tools while assessing for adverse effects.
- Employ methods to counsel patients and caregivers about the safe use of ER/LA opioid analgesics, including proper storage and disposal.
- Review/assess general and product-specific drug information concerning ER/LA opioid analgesics, identifying potential adverse effects of ER/LA opioids.
RPC Commercial Support Disclosure Statement
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing the member companies. This activity is intended to be fully-complaint with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration (FDA).
ASAM’s CO*RE REMS CME Information
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Addiction Medicine designates this educational activity for a maximum of 3 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The 2013 TnSAM Addiction Medicine Conference
“Treat Addiction. Save Lives.”
This one and one-half day interdisciplinary conference is designed
- to increase awareness among health care providers of the high prevalence of substance use disorders
- to improve the ability to assess & treat patients for substance use disorders
- to assist healthcare providers in integrating treatment methods designed to improve care outcomes.
- to provide physicians with continuing medical education required by the state of Tennessee to maintain licensure.
An Outstanding Array of Topics and Speakers
Hooked But Not Hopeless – Sherry Hoppe, Ph.D
Tennessee Department of Health and TMA Response to Tennessee’s Prescription Drug Abuse Epidemic – Mitch Mutter, M.D.
Dual Diagnoses: Management of co-occurring disorders in Addicted Patients – Terry Holmes, M.D.
Opiate Dependency in Pregnancy – Tom Cable, M.D.
Addiction Medicine Talking Points – John Standridge, M.D.
Evidenced-Based Behavioral Treatments for Addiction – James Finch, M.D.
The Neurobiology of Reward and Addiction – John Standridge, M.D.
Lunch and Learn with Faculty
Counseling Skills Workshop: Motivational Interviewing, Cognitive Behavioral Therapy, and
Mindfulness – James Finch, M.D. and Jane Finch, L.C.S.W.
- become more knowledgeable about the science and practice of addiction medicine
- become more knowledgeable about the neurobiology of reward & addiction
- become more knowledgeable about the medical, social, psychological, & spiritual needs of alcohol & drug dependent individuals
- increase their comfort level and capability to address these issues with the lay public, such as civic groups & legislators
- become more knowledgeable about prescription medication abuse, especially regarding appropriate prescribing guidelines, the TMA’s response, & the behavioral strategies necessary to intervene
- become more knowledgeable about educating patients on appropriate & inappropriate use of controlled substances
- become more knowledgeable about managing opiate dependency in pregnancy
- become more knowledgeable about effectively treating co-occurring psychiatric disorders in addicted patients
- develop the skills necessary to employ the proven methodologies of motivational interviewing & cognitive behavioral therapy, & to promote mindfulness practices in clients & patients.
Continuing Medical Education Credits
AMA: The University of Tennessee College of Medicine designates this live activity for a maximum of 12.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. AAPA: American Academy of Physician Assistants accepts Category 1 credit toward the AMA Physician’s Recognition Award from organizations accredited by the ACCME. The AAPA has complete reciprocity with the ACCME. CEU: Certificates of attendance and CEUs will be provided for non-physicians attending this educational activity.
Accreditation: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Tennessee College of Medicine and the Tennessee Society of Addiction Medicine. The University of Tennessee College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.